Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial

2019151 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 72, Issue 3, pp. 441-449

Field-Weighted Citation Impact: 12.29